Dr. Alexander MacGregor is the Founder and president of the Toronto Institute of Pharmaceutical Technology (TIPT®) – North America’s premier post-graduate institute of pharmaceutical sciences, technology and research. He is also a distinguished professor of Bio-pharmaceutics and Pharmaceutical Technology.

​

Dr. MacGregor is a noted expert in translating pharmaceutical knowledge into sustainable business. He has consulted and remain a consultant to several multi-national companies in pharmaceutical and healthcare sector such as GlaxoSmithKline, Valeant, Teva, Patheon, SunPharma, Beijing Double-Crane Pharma, Therapure, and Apotex to name a few.  He was appointment by the Government of China as an International Advisor in the field of pharmaceutical technology and research through a nomination proffered by the City of Beijing and Beijing Double-Crane Pharmaceutical Co: China’s third largest pharmaceutical company.

 

Dr. MacGregor’s expertise includes design and implementation of GMP production facilities and testing laboratories for pharmaceuticals, natural health products, biologics and cannabis industry. He has consulted and assisted several companies in Ontario and British Columbia in the medical cannabis sector obtain Health Canada Licenses as producers and dealers under ACMPR and NCR regulations. He is a recipient of several global patents in the field of medical treatments and pharmaceutical drug delivery technologies most notably from Canada, US, Australia, Europe, Latin America, China, India and Japan.

 

Dr. MacGregor is a recipient of several community awards including Harry Jerome Trailblazer award and African Canadian Achievement award for Science & Technology

 

He received honours degree (Magna Cum Laude-BSc) in Medical Biochemistry and Doctor of Philosophy (Ph.D.) in Clinical Pharmacology from the University of Wales and the Royal Post-Graduate Medical School London, UK.